1 |
2D 1H-15N HSQC |
0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O |
0 |
90% H2O/10% D2O |
6.5 |
1 |
303.15 |
2 |
3D HNCACB |
0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O |
0 |
90% H2O/10% D2O |
6.5 |
1 |
303.15 |
3 |
3D HNCO |
0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O |
0 |
90% H2O/10% D2O |
6.5 |
1 |
303.15 |
4 |
3D 1H-15N NOESY |
0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O |
0 |
90% H2O/10% D2O |
6.5 |
1 |
303.15 |
5 |
3D 1H-15N TOCSY |
0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O |
0 |
90% H2O/10% D2O |
6.5 |
1 |
303.15 |
6 |
3D 1H-13C NOESY (edited) |
0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O |
0 |
90% H2O/10% D2O |
6.5 |
1 |
303.15 |
7 |
3D 1H-13C NOESY (filtered) |
0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor, 90% H2O/10% D2O |
0 |
90% H2O/10% D2O |
6.5 |
1 |
303.15 |